Revolo Biotherapeutics Announces the Appointment of Tunde Otulana, M.D., to its Board of Directors
Revolo Biotherapeutics, a Company developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, announced the appointment of industry veteran Tunde Otulana,…
Read More...
Read More...